Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXUC4N
|
||||
| Drug Name |
N-((4-benzyl-3,4-dihydro-2H-benzo[b][1,4]oxazin-2-yl)methyl)-3-(1H-indol-3-yl)propan-1-amine
|
||||
| Synonyms |
CHEMBL381542
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C27H29N3O
|
||||
| Canonical SMILES |
C(CNCC1CN(Cc2ccccc2)c3ccccc3O1)Cc4c[nH]c5ccccc45
|
||||
| InChI |
InChI=1S/C27H29N3O/c1-2-9-21(10-3-1)19-30-20-23(31-27-15-7-6-14-26(27)30)18-28-16-8-11-22-17-29-25-13-5-4-12-24(22)25/h1-7,9-10,12-15,17,23,28-29H,8,11,16,18-20H2
|
||||
| InChIKey |
WQZDAFQSPAHESA-UHFFFAOYSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | 5-hydroxytryptamine 1A receptor | Target Info | [1587926] | ||
| Sodium-dependent serotonin transporter | Target Info | [1587926] | |||
| NetPath Pathway | TCR Signaling Pathway | ||||
| PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
| 5HT1 type receptor mediated signaling pathwayP04373:5HT1 type receptor mediated signaling pathway | |||||
| 5HT2 type receptor mediated signaling pathway | |||||
| 5HT3 type receptor mediated signaling pathway | |||||
| 5HT4 type receptor mediated signaling pathway | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.